14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
NBP vs ENTX: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, NBP (NBP) is the stronger overall head-to-head candidate over Entera Bio Ltd. (ENTX) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NBP carries a Unified Composite Score of 51.9/100 (HOLD) at $0.79 (2.7x Forward P/E, 0.0% operating margin), whereas ENTX carries 48.1/100 (HOLD) at $3.04 (N/M Forward P/E, 0.0% operating margin).
Technical & Structure Timing Caution: NBP is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 20.1); meanwhile ENTX trades in a Markup technical trend (CONSOLIDATION options phase, RSI 50.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NBP vs ENTX. Trailing 12-month operating profitability (NBP 0.0% vs ENTX 0.0%) and valuation multiples (NBP 2.7x vs ENTX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Biotechnology value chain with $560.7M market capitalization and 0.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ NBP vs ENTX Key Questions & Quantitative Answers
As of Nov 16, 2026, NBP (NBP) is the stronger overall head-to-head candidate over Entera Bio Ltd. (ENTX) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NBP carries a Unified Composite Score of 51.9/100 (HOLD) at $0.79 (2.7x Forward P/E, 0.0% operating margin), whereas ENTX carries 48.1/100 (HOLD) at $3.04 (N/M Forward P/E, 0.0% operating margin). Technical & Structure Timing Caution: NBP is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 20.1); meanwhile ENTX trades in a Markup technical trend (CONSOLIDATION options phase, RSI 50.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
NBP leads the Growth & Scale pillar: NBP posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with ENTX at -100.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, NBP generates N/A in USD-normalized revenue versus N/A for ENTX. In operating R&D and SG&A reinvestment, NBP deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ENTX.
NBP screens cheaper on headline valuation multiples. NBP trades at 2.7x Forward P/E, 2.7x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas ENTX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NBP (-59.1% ROE) versus ENTX (-138.9% ROE) capital efficiency.
In options market volatility and institutional positioning, NBP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.66β · 81% Vol realized risk). By comparison, ENTX carries 164.0% implied volatility (47th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (1.07β · 46% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.